Trulicity vs Ozempic
Trulicity vs Ozempic: these brands hold two different GLP-1 medicines, dulaglutide and semaglutide, from two makers.
Paste this code into your page. It shows the GLP-1 comparison chart with one plain credit link.
Learn
More about this page
Both act on the receptor for GLP-1, a gut hormone that raises insulin and lowers glucagon after meals. Both labels are about adults with type 2 diabetes, and both are once weekly shots. This page puts the two FDA labels side by side.
Source: Drucker DJ, Cell Metabolism 2018, PMID 29617641.
The two labels side by side
| Label fact | Trulicity | Ozempic |
|---|---|---|
| Medicine (molecule) | dulaglutide | semaglutide |
| Type | GLP-1TRULICITY® is a glucagon-like peptide-1 (GLP-1) receptor agonist | GLP-1OZEMPIC is a glucagon-like peptide 1 (GLP-1) receptor agonist |
| Maker on the label | Eli Lilly and Company | Novo Nordisk Pharmaceutical Industries, LP |
| Taken as | Injection: pen solution in a single-dose pen | Injection: pen or prefilled syringe single-patient-use pens ... single-dose prefilled syringe |
| How often, per label | Once weekly Administer TRULICITY once weekly, any time of day, with or without food. | Once weekly Administer OZEMPIC once weekly, on the same day each week |
| Approved uses, per label |
|
|
| Boxed warning | Yes WARNING: RISK OF THYROID C-CELL TUMORS | Yes WARNING: RISK OF THYROID C-CELL TUMORS |
| Label read | Trulicity label, version 62, effective June 16, 2026 | Ozempic label, version 20, effective June 1, 2026 |
| FDA approval record | BLA125469, first approved September 18, 2014 | NDA209637, first approved December 5, 2017 |
Every line quotes the label. The label links go to the version we read on DailyMed.
Where the two labels differ
- The medicine and maker. Trulicity holds dulaglutide from Eli Lilly. Ozempic holds semaglutide from Novo Nordisk.
- Who the cardiovascular use covers. Trulicity's label names adults with type 2 diabetes who have established cardiovascular disease or several cardiovascular risk factors. Ozempic's label names adults with type 2 diabetes and established cardiovascular disease. The exact words are in the table.
- Ages. Trulicity's label includes children 10 and older for blood sugar control. Ozempic's label lists adults.
- Kidney use. Only the Ozempic label lists a kidney use, for adults with type 2 diabetes and chronic kidney disease.
- Application type. Trulicity was approved under a biologics license application (BLA) in 2014. Ozempic was approved under a new drug application (NDA) in 2017.
More side by side pages
Ozempic has a brand twin with the same medicine: see Ozempic vs Wegovy. To compare Trulicity with any other label, such as Zepbound or Mounjaro, pick it in the GLP-1 comparison chart. The list of GLP-1 drugs names every brand.
Questions
What is the difference between Trulicity and Ozempic?
Trulicity and Ozempic hold different medicines from different makers: dulaglutide from Eli Lilly and semaglutide from Novo Nordisk. Both labels cover type 2 diabetes. The Ozempic label also lists a kidney use. The Trulicity label also covers children 10 and older for blood sugar control.
Is Trulicity the same as Ozempic?
No. Trulicity and Ozempic are different medicines with different labels. Both labels call their medicine a GLP-1 receptor agonist taken once weekly.
Sources
4 sources with read dates
- Trulicity label on DailyMed, Eli Lilly, version 62 of 2026-06-16, read 2026-10-06
- Ozempic label on DailyMed, Novo Nordisk, version 20 of 2026-06-01, read 2026-10-06
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1, Drucker DJ, Cell Metabolism 2018, PMID 29617641, abstract read on PubMed 2026-10-06
- Drugs@FDA application records for BLA 125469 and NDA 209637, US Food and Drug Administration, via the openFDA drugsfda API, read 2026-10-06